Originally in the business of transgenics - mouse models - in 1993 Genpharm and Stratagene combined their mouse models to create a single model for the testing of tumorigenesis and mutagenesis As a vehicle to take itself public, Strategene - in the business of developing tools for the life sciences/research market - in June 2004 undertook a reverse merger with the publciy traded, diagnostic instruments and reagents systems manufacturer Hycor Biomedical. Organized around innovative technologies for life science researchers in fields spanning molecular biology, genomics, proteomics, drug discovery and toxicology, in April 2007 Stratagene Inc was acquired by Agilent Technologies Inc.
